Natus Medical Story

Natus Medical Incorporated -- USA Stock  

USD 39.2  0.45  1.13%

Macroaxis does not monitor all media channels or aggregates social signals for Natus Medical. But even though we do not provide professional-grade financial sentiment analysis on Natus Medical Incorp, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Natus Medical. Check also Natus Medical Hype Analysis, Natus Medical Correlation and Natus Medical Performance
Payment of 2231 shares by Austin Noll of Natus Medical subject to Rule 16b-3
Filed transaction by Natus Medical Inc officer. Payment of exercise price or tax liability by delivering or withholding securities

Natus Medical Incorporated insider trading alert for payment of common stock $0.001 par value per share by Austin Noll, VPGM Neurology, on August 17, 2017. This event was filed by Natus Medical Inc with SEC on 2017-08-17. Statement of changes in beneficial ownership - SEC Form 4. Austin Noll is currently serves as vice president and general manager - neurology strategic business unit of Natus Medical Incorp

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on August 17, 2017 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 3.7% . The trading delta at closing time when the story was published against the current closing price is 16.59% .

Similar stores for Natus Medical

Kennametal Holder Bronson Point Management Decreased Holding by 314500 Lyon Street Capital Has
Hill Country TimesBeddow Capital Management Has Raised Its Natus Medical Position Winmark Has 2.35 Sentiment San TimesFull coverage
over two weeks ago at 
Tdam USA Inc. Trims Stake in Natus Medical Incorporated
Natus Medical logo Tdam USA Inc. cut its stake in shares of Natus Medical Incorporated by 45.1 percent in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional ... Natus Medical Incorporated VP Dong Chune Christopher Chung Sells ... - The Ledger Gazette Gratry and Company Has Decreased Accenture Plc Holding Natus Medical ... - Herald KS
over a month ago at 
Healthsouth Received 55.0 Target From Mizuho Securities Natus Medical s Sentiment Is 1.17
NormanObserver.comHealthsouth Corporation - HLS - Stock Price Today - Zacks Zacks Investment ResearchFull coverage
over three months ago at 
Exercise or conversion by Kenneth Traverso of 5000 shares of Natus Medical subject to Rule 16b-3
Macroaxis News
Filed transaction by Natus Medical Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Did you try this?

Run Portfolio Reporting Now

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
Hide  View All  NextLaunch Portfolio Reporting


EBITDA Comparative Analysis
      Natus Medical Comparables 
Natus Medical is currently under evaluation in ebitda category among related companies. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.